Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,666,578
  • Shares Outstanding, K 96,551
  • Annual Sales, $ 245,890 K
  • Annual Income, $ -31,250 K
  • 60-Month Beta N/A
  • Price/Sales 23.46
  • Price/Cash Flow N/A
  • Price/Book 13.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.21
  • Number of Estimates 1
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.78 +20.32%
on 03/23/20
78.71 -25.44%
on 03/04/20
-18.26 (-23.73%)
since 03/03/20
3-Month
48.78 +20.32%
on 03/23/20
108.36 -45.84%
on 01/29/20
-16.87 (-22.33%)
since 01/03/20

Most Recent Stories

More News
10x Genomics Appoints Kim Popovits to Board of Directors

10x Genomics, Inc. (Nasdaq: TXG) today announced the appointment of Kim Popovits, former Chairman of the Board, President and Chief Executive Officer of Genomic Health, Inc., to the company's Board of...

GHDX : 63.44 (-0.69%)
TXG : 58.69 (-1.76%)
EXAS : 55.75 (-3.21%)
10x Genomics: 4Q Earnings Snapshot

PLEASANTON, Calif. (AP) _ 10x Genomics Inc. (TXG) on Tuesday reported a loss of $7.1 million in its fourth quarter.

TXG : 58.69 (-1.76%)
Medical Products Stock Feb 6 Earnings Roster: BDX, CAH & More

Despite the ongoing US-China trade war, increased focus on innovation is likely to have driven performance of medical products players' quarterly performance.

ABT : 79.45 (+0.01%)
TMO : 282.21 (-1.86%)
ABMD : 141.40 (-1.31%)
BSX : 31.17 (+0.39%)
SYK : 148.07 (-1.01%)
MDT : 86.27 (+0.14%)
BDX : 226.73 (-2.81%)
CAH : 46.61 (+0.41%)
TXG : 58.69 (-1.76%)
10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference

10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

JPM : 84.05 (-3.95%)
TXG : 58.69 (-1.76%)
TXG Crosses Above Average Analyst Target

In recent trading, shares of 10x Genomics Inc have crossed above the average analyst 12-month target price of $64.75, changing hands for $67.85/share. When a stock reaches the target an analyst has set,...

TXG : 58.69 (-1.76%)
10x Genomics: 3Q Earnings Snapshot

PLEASANTON, Calif. (AP) _ 10x Genomics Inc. (TXG) on Thursday reported a loss of $9.6 million in its third quarter.

TXG : 58.69 (-1.76%)
10x Genomics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

10x Genomics (Nasdaq: TXG) today announced the closing of its initial public offering of 11,500,000 shares of its Class A common stock, which includes the exercise in full of the underwriters' option to...

JPM : 84.05 (-3.95%)
TXG : 58.69 (-1.76%)
Trade TXG with:

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

2nd Resistance Point 62.74
1st Resistance Point 60.71
Last Price 58.69
1st Support Level 57.35
2nd Support Level 56.02

See More

52-Week High 108.36
Fibonacci 61.8% 84.20
Fibonacci 50% 76.73
Fibonacci 38.2% 69.27
Last Price 58.69
52-Week Low 45.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar